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Abstract: Staphylococcus aureus enterotoxins have immunomodulatory properties. In this 
study, we show that Staphylococcal enterotoxin A (SEA) induces a strong proliferative 
response  in  a  murine  T  cell  clone  independent  of  MHC  class  II  bearing  cells.  SEA 
stimulation  also  induces  a  state  of  hypo-responsiveness  (anergy).  We  characterized  the 
components  of  the  T  cell  receptor  (TCR)  during  induction  of  anergy  by  SEA.  Most 
interestingly,  TCR  zeta  chain  phosphorylation  was  absent  under  SEA  anergizing 
conditions, which suggests an uncoupling of zeta chain function. We characterize here a 
model system for studying anergy in the absence of confounding costimulatory signals. 
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1. Introduction 
Staphylococcus aureus enterotoxins have been implicated in a number of acute and chronic human 
diseases  including  food  poisoning,  tampon  related  toxic  shock,  scalded  skin  syndrome,  Kawasaki 
syndrome, and shock [1–3]. The toxins produced by S. aureus include Staphylococcal enterotoxin A 
(SEA), B, C1, C2, C3, D, E, G-R, U, and toxic shock syndrome toxin-1 (TSST-1). Collectively, these 
toxins are classified as superantigens since they bind to major histocompatibility complex (MHC) class 
II molecules and are recognized by essentially all T cells expressing certain T cell receptor (TCR) 
variable β (Vβ) alleles [1,2]. This suggests that up to 20% of the T cell repertoire could be activated by 
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a single superantigen. Finally, another characteristic which distinguishes a superantigen from a normal 
antigen is the lack of a requirement for processing by the antigen presenting cell (APC).  
Complete T cell activation requires the recognition of antigen presented in the context of MHC 
class I or II to the TCR and the delivery of costimulatory signals via either the interaction of CD28 with 
B7-1/-2, or by the activation of cytokine receptors. The first of these signals is mediated via the TCR 
which is a complex of proteins consisting of the α and β heterodimer along with the γ, δ, and ε chains 
of CD3 and a homodimer of the ζ chain. These subunits of CD3 as well as the ζ chain have been shown 
to possess cytoplasmic tails which become rapidly phosphorylated upon normal stimulation of the TCR 
[4]. In addition, kinases, such as, p56lck, p59fyn, and zap-70 are brought in close proximity of the TCR 
by CD4 and other costimulatory molecules and are rapidly phosphorylated following TCR stimulation 
[5–11]. The results of these signaling events are the production of IL-2, the autocrine IL-2-induced 
activation of the IL-2 receptor complex, and clonal expansion of the T cell through proliferation. 
However,  an  incomplete  or  partial  stimulation  of  T  cells  via  the  TCR  in  the  absence  of 
costimulatory signals results in a state of tolerance or anergy [12]. Anergy can be induced by several 
different methods. The first described induction of anergy involved complete TCR stimulation in the 
presence of neutralizing antibodies to IL-2 and IL-2 receptor [13]. It was suggested that conditions 
which favor anergy induction are insufficient for normal IL-2 production and the absence of autocrine 
stimulation  by  IL-2  results  in  the  development  of  anergy.  Furthermore,  Boussiotis  et  al.  [14] 
demonstrated that stimulation of human T cells with antigen in the absence of CD28 signaling, but in 
the presence of IL-2, IL-4, or IL-7, inhibited the development of anergy. Other models employed 
cross-linking of CD3 in the absence of costimulation, or peptide with a single amino acid substitution 
(altered peptide ligand; APL) presented by live APCs to induce anergy [11,15–17]. Our laboratory and 
others have demonstrated that superantigens can induce anergy in the absence of MHC class II bearing 
cells in murine and human T cells [18–20]. Interestingly, superantigen-induced anergy was not avoided 
when exogenous IL-2 was present [19,20]. This is a fundamental difference between in vitro models of 
anergy  induction  where  antigen  is  presented  by  functionally  impaired  APCs.  Similarly,  several 
investigators  have  demonstrated  anergy  induction  following  superantigen  administration  in  vivo  
[21–25].  These  data  suggest  that,  in  contrast  to  normal  antigenic  stimulation,  superantigens  may 
provide a distinct and physiologically relevant signal(s) via the TCR to induce a state of anergy.  
Here we report an in vitro model of anergy using superantigen in the absence of MHC class II 
bearing cells to examine the proximal TCR signaling events that lead to the induction of an anergic 
phenotype. The advantage of this experimental system is that T cell clonal anergy is induced under 
highly simplified conditions where there are no complicating signals contributed by the APCs. The 
purpose of the present studies was to characterize the proximal signaling events following induction of 
anergy under these conditions. In this system, the A.E7 clone was anergized by SEA in the absence of 
APCs, while the cells undergo a dose-dependent proliferative response, and remain responsive to IL-2. 
We  find  that  p56lck  expression,  but  not  p59fyn  or  ZAP-70,  is  reduced  rapidly  following  anergy 
induction with SEA alone. Importantly, under these conditions, the zeta chain of the TCR failed to 
become hyper-phosphorylated, in contrast to  conditions of normal T cell activation. Finally, these 
studies  demonstrate  that  the  failure  to  hyper-phosphorylate  zeta  chain  is  mediated  directly  by  the 
ligation of the TCR by superantigen.  
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2. Results and Discussion 
2.1. The role of APCs in the SEA-induced proliferation of the A.E7 T cell clone  
We wanted to determine the capacity of A.E7 T cells to proliferate in response to SEA in the 
presence or absence of syngeneic class II-bearing antigen presenting cells (APC). The A.E7 cells were 
stimulated  for  two  days  in  culture  with  SEA  (0.001–25  ng/mL)  with  or  without  irradiated  B10.A 
splenocytes. The results in Figure 1 demonstrate a strong proliferative response of the A.E7 T cell 
clone stimulated with SEA (EC50 approximately 0.01 ng/mL) presented by APC. Furthermore, in the 
absence of APCs, SEA also induces a comparable level of proliferation in the A.E7 T cell clone (EC50 
approximately  0.2  ng/mL),  however  the  response  in  the  absence  of  APCs  requires  approximately  
20-fold higher concentration of SEA. These results are consistent with previous results reported from 
this laboratory [18,19], and others [26,27], which have shown that T cells may exhibit a proliferative 
response to superantigen in the absence of intact APCs. 
Figure 1. A.E7 proliferative response to SEA. A.E7 cells were cultured with the designated 
concentrations of SEA for 48 hours in the presence (￿) or absence (￿) of irradiated B10.A 
splenocytes (2.5 × 10
5 cells/culture). The proliferative response was assessed after 48 hours. 
The results are representative of more than three independent experiments. The error bars 
represent standard error. The background proliferation of the A.E7 clone was 168 CPM in 
this experiment. 
 
In  addition,  the  A.E7  T  cell  clone  can  respond  to  other  stimuli,  including  IL-2.  We  tested  the 
response  of  the  A.E7  cells  to  IL-2  in  the  absence  of  APCs,  and  the  results  show  a  strong  
dose-dependent proliferative response (Figure 2). The cells were cultured with IL-2 (0.7–100 U/mL) 
for 48 hours in the absence of any other stimulus. IL-2 induced a proliferative response in the A.E7 
cells comparable to normal antigenic stimulation. These results demonstrate that resting A.E7 cells 
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have  an  intact  IL-2  receptor  and  IL-2  receptor  signaling  pathway(s).  Furthermore,  these  data  are 
consistent with previously published observations that T cell proliferation alone cannot prevent anergy 
induction [28].  
Figure 2. Proliferative response of the A.E7 clone to IL-2 stimulation. A.E7 cells were 
cultured with the designated concentrations of IL-2 for 48 hours, and the proliferation was 
determined by [
3H]-thymidine incorporation. Background proliferation was 283 CPM for 
this  experiment.  These  results  are  representative  of  two  experiments.  The  error  bars 
represent standard error. 
 
2.2. SEA-induced T cell anergy 
In an effort to examine the functional activity of the stimulated A.E7 cells, the cells were stimulated 
with SEA in the absence of MHC class II-bearing cells (Figure 3). After two days in this first stage of 
culture with SEA, the cells were washed and re-cultured for two to four days in fresh medium to allow 
the clone to rest. In the second stage of the experiment, the ability of the cells to proliferate in response 
either to peptide antigen or SEA presented by irradiated APCs or to exogenous IL-2 was determined 
(data not shown). A dose-dependent relationship was observed between the concentration of SEA used 
to stimulate the clone in the first stage of the assay and the reduced response to antigenic stimulation in 
the second stage (Figure 3). However, the A.E7 clone stimulated with SEA (up to 100 ng/mL) in the 
first stage maintained an essentially normal proliferative response to exogenous IL-2 stimulation in the 
second stage. These studies were carried out with a two day resting period between the stimulation 
with  peptide  antigen  or  SEA  (stage  1)  and  the  analysis  of  T  cell  function  (stage  2).  Additional 
experiments were carried out with up to seven days between the end of SEA stimulation and the 
initiation of the second stage, and we observed essentially the same degree of anergy (data not shown). 
Cells anergized under the latter conditions also retained normal responsiveness to IL-2.  
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Figure 3. Dose-dependent SEA-induced anergy induction in the A.E7 clone. A.E7 cells 
were stimulated for 48 hours in culture (first stage) with SEA in the absence of APCs. The 
cells were washed and re-cultured for 48 hours in medium alone. The A.E7 cells were 
cultured for 48 hours (second stage) with either irradiated APCs (black bars) presenting 
peptide antigen (10 µM) or IL-2 (20 U/mL; gray bars). These data are representative of 
more  than  three  independent  experiments.  The  error  bars  represent  standard  error.  The 
background proliferation of the A.E7 cells was 1,290 CPM. 
 
2.3. Expression of TCR-proximal signaling components in anergized A.E7 cells 
Based on our previous results, superantigen-induced anergy in murine A.E7 T cells did not appear 
to  be  due  to  the  simple  failure  of  the  stimulated  T  cells  to  produce  IL-2  [19].  Furthermore,  we 
previously  showed  that  the  anergy  was  not  the  result  of  TCR  modulation  [19].  However,  we 
considered  the  possibility  that  the  signaling  components  of  the  TCR  may  be  altered  as  a  part  of 
inducing an anergic state. In an effort to address this question, the A.E7 clone was stimulated for 24 
and 48 hours with or without SEA (25 ng/mL) in the absence of APCs. The A.E7 clone was harvested, 
washed, and lysed. The lysates were separated by SDS-PAGE and probed with antibodies specific for 
TCR-proximal signaling components. For comparative purposes within an assay, a volume of whole 
cell  lysate  from  an  equivalent  number  of  cells  was  added  to  each  lane.  The  results  show  that  
SEA-stimulation for either 24 or 48 hours resulted in a decrease in the expression of p56lck in the 
A.E7 clone (Figure 4A). Densitometric analysis of these bands revealed a 40% decrease in p56lck 
expression relative to the unstimulated control. These data are consistent with previously reported 
observations of anti-CD3-induced anergy [29]. Lck expression in the A.E7 clone was also analyzed 
after stimulation for 48 hours with SEA in the presence or absence of exogenous IL-2 (20 U/mL). 
Stimulation  with  the  combination  of  SEA  and  IL-2  did  not  alter  the  40%  decrease  in  p56  lck 
expression  that  was  observed  with  SEA  stimulation  alone  (data  not  shown).  Moreover,  IL-2 
stimulation alone did reduce the expression of p56lck by 50% (data not shown). 
CPM (x10-3)
0 25 50 75 100
S
E
A
 
(
n
g
/
m
l
)
0
0.001
0.01
0.1
1
10
100
APC + Ag
IL-2
First Stage:
Second Stage:Toxins 2010, 2  
 
 
1709
We also analyzed the expression of the TCR-proximal components p59fyn, ZAP-70, and p16 zeta 
chain (Figure 4B and 4C). Again, the A.E7 clone was stimulated with and without SEA (25 ng/mL) for 
48 hours, and the lysates were separated by SDS-PAGE and immunoblotted with antibodies specific 
for either ZAP-70, p59fyn, or zeta chain. The expression of these signaling components in the A.E7 
clone was not altered by stimulation with SEA for 48 hours. The observation that p59fyn expression 
was not altered is in contrast to observations reported for anti-CD3-induced anergy where p59fyn 
expression dramatically increased [29]. As a control for these experiments, analysis of expression of 
the housekeeping protein, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was carried out as 
an  additional  means  of  normalization  of  lysates  loaded  in  each  lane.  These  results  show  that 
stimulation of the A.E7 cells for 48 hours with SEA did not affect the expression of GAPDH in the 
A.E7 cells (Figure 4C). The analysis of GAPDH for the purposes of normalization was performed in 
every  assay.  These  results  demonstrate  that,  with  exception  of  p56lck,  the  components  of  the  
TCR-proximal signal transduction pathway were present at a normal level at 24 to 48 hours in the 
SEA-anergized A.E7 cells.  
Figure  4.  Reduced  p56LCK  expression  in  SEA-anergized  A.E7  cells.  A.E7  cells  were 
stimulated with or without SEA (25 ng) for various times. Panel A, lysates were generated 
and analyzed (50 µg) for p56lck; Panel B, A.E7 cells were treated with SEA for 48 hours 
and lysates were analyzed for ZAP-70; Panel C, A.E7 cells were treated with SEA for  
48 hours and lysates were analyzed for p59fyn, zeta chain, and GAPDH. Lanes 1 and 4 
were loaded with approximately 150, 100, and 20 µg of lysate, respectively; Lanes 2 and 5 
were loaded with approximately 100, 50, and 10 µg of lysate, respectively; Lanes 3 and 6 
were loaded with approximately 50, 25, and 5 µg of lysate, respectively. These results are 
representative of three independent experiments. 
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2.4. TCR-proximal signaling components during the induction phase of anergy 
Published results have demonstrated that TCR-proximal tyrosine kinase signaling may be altered 
early  during  the  induction  of  anergy  [16,29–32].  For  this  reason,  we  measured  the  expression  of  
TCR-proximal  signaling  components  in  the  A.E7  clone  stimulated  with  SEA  (25  ng/mL)  in  the 
presence or absence of APCs for 30 minutes (Figure 5). We show in Figure 4 that ZAP-70 expression 
levels were not altered by SEA stimulation. In Figure 5 (Box B), we confirm this and demonstrate that 
ZAP-70 expression is also not changed in the A.E7 cells following stimulation under normal activation 
conditions (lane 3) when compared to anergic stimuli (lane 2). However, the phosphorylation state of 
ZAP-70 was increased with normal activation stimuli but not with anergizing stimuli (SEA alone) 
(Figure 5, Box A). These results suggest that either ZAP-70 is not recruited to the TCR or that ZAP-70 
does not become phosphorylated by SEA in the absence of APCs. These data are consistent with 
observations reported for anergy induction using anti-CD3 antibodies [11]. 
Figure 5. Uncoupling of TCR zeta chain during superantigen-induced anergy development. 
A.E7 cells were cultured with medium (lane 1), SEA (lane 2), or SEA presented by APCs 
(lane 3) for 30 minutes. As a control, APCs were also cultured with SEA (lane 4) for  
30  minutes.  APCs  were  depleted  of  T  cells  and  pre-treated  with  SEA  (25  ng/mL)  for  
30 minutes prior to addition of A.E7 cells. Lysates were prepared and analyzed by western 
blotting with anti-phosphotyrosine (Box A), anti-ZAP-70 antibody (Box B), or anti-zeta 
chain  antibodies  (Box  C).  Lysates  in  box  A  and  C  were  immunoprecipitated  with  
anti-CD3ε  antibody  followed  by  immunoblotting  with  anti-phosphotyrosine  antibody. 
These results are representative of three independent experiments.  
 
During normal T cell activation, the zeta chain is typically hyper-phosphorylated. Cells anergized 
using live APCs presenting altered peptide ligand (APL) have shown that under these conditions the 
zeta chain does not become fully hyper-phosphorylated [16,32]. These results are in contrast to the 
hyper-phosphorylation of the zeta chain observed following anergy induction via antigen presented by 
chemically-inactivated APCs [32]. In light of these results, we wished to determine whether the zeta 
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chain became hyper-phosphorylated upon stimulation with SEA in the presence or absence of APCs. 
Lysates of the A.E7 clone cultured in medium or stimulated for 30 minutes with SEA, APCs, or APCs 
plus SEA were prepared and analyzed by western blotting for the non-phosphorylated form (p16) of 
zeta chain (Figure 5). We observed that expression of the non-phosphorylated form of zeta chain (p16) 
in  the  SEA-stimulated  A.E7  cells  was  unchanged  when  compared  to  non-stimulated  A.E7  cells 
(Figure 5, Lanes 1 vs. 2). In contrast, when APCs were present with SEA, there was a significant 
reduction of the non-phosphorylated form (p16) of zeta chain (Figure 5, Box D). This loss of p16 zeta 
chain could be due either to degradation of the protein or by hyper-phosphorylation which would 
change  the  apparent  size  during  electrophoresis.  To  determine  if  p16  was  hyperphosphorylated, 
immunoprecipitation with anti-CD3ε antibody was used to co-precipitate the zeta chain followed by 
western  blotting  with  anti-phosphotyrosine  antibodies  (Figure  5,  Box  C).  Bands  representing  the 
hyper-phosphorylated forms of zeta chain (p21 and p23) were observed only from lysates of A.E7 cells 
that were stimulated with normal activation conditions (SEA presented by APCs; Figure 5, Lane 3). 
Immunoprecipates from lysates of A.E7 cells that were not stimulated or stimulated with SEA alone 
(anergizing condition) did not contain the p21/23 bands. Taken together, these results indicate that a 
normal  T  cell  activation  stimulus  can  induce  hyper-phosphorylation  of  the  zeta  chain  while  an 
anergizing  stimulus  (SEA  alone)  cannot,  even  though  both  stimuli  induce  a  strong  proliferative 
response in the A.E7 cells. Stimulation of T cells with SEA in the absence of APCs appeared to result 
in the uncoupling of the zeta chain from the TCR/CD3 complex suggesting the possibility that these 
altered signaling events may have been involved in the development of anergy.  
Our approach has been to examine the induction of T cell anergy using SEA treatment of the A.E7 
clone in vitro, and it should be pointed out that several other investigators have demonstrated that this 
superantigen induces a state of anergy with administration in vivo [33–36]. We acknowledge that using 
a single clone is a limitation with these studies since it may or may not reflect completely the in vivo 
state. However, the A.E7 clone used here is one of the first and most extensively characterized T cell 
clones to study the state of anergy in vitro. This offers an advantage to studying TCR signaling events 
because  comparisons  between  different  anergic  stimuli  can  be  drawn.  Likewise,  the  use  of  a 
superantigen  to  stimulate  a  clone  allows  for  all  of  the  cells  within  a  population  to  respond  both 
homogenously and maximally. This is in contrast to using naïve T cells since a single superantigen will 
likely only stimulate up to 20% of the T cell repertoire [3]. Finally, the ability of a superantigen to 
induce anergy in the absence of MHC class II bearing cells allows the signaling events to be isolated 
from any interference of costimulatory signaling molecules. 
The induction of anergy by superantigens has been demonstrated by our lab and others [19,37–39]. 
In the present study, we observed a failure of ZAP-70 and zeta-chain to become phosphorylated in 
response to SEA stimulation during the induction phase of anergy. Similar observations were found 
in vivo after anergy was induced [37]. In this case, mice were primed with SEB, and a week later the 
TCR Vβ-specific T cells were re-challenged with SEB presented by irradiated splenocytes as a sources 
of  antigen  presenting  cells.  The  SEB-primed  T  cells  were  not  able  to  phosphorylate  ZAP-70  or  
zeta-chain upon re-challenge. On the other hand, studies where SEB is used to induce anergy in vivo 
show that it is the CD4 memory, but not naïve, T cells which fail to bring ZAP-70 into the TCR  
zeta-chain complex for phosphorylation and subsequent activation [38]. These data, in combination 
with our in vitro observations, suggest that the mechanism of anergy induction by superantigens may Toxins 2010, 2  
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share similar characteristics in vitro and in vivo. Furthermore, these data suggest that the induction of 
anergy in vivo by superantigens may occur in the absence of antigen presenting cells. 
Another issue which may be important for SEA-induced anergy in the A.E7 clone is that p56lck 
levels are reduced. Fujimaki et al. [39] demonstrated that the interaction of CD45 and p56lck was 
suppressed in TSST-1-anergized thymic CD4+ cells and that this played a role in sustaining an anergic 
state. Since p56lck levels are reduced in our system, it is possible that a similar mechanism involving 
CD45 and p56lck interactions proposed the latter investigators is taking place. Regardless, it seems 
that there may be common processes for the induction of anergy by superantigens. 
The induction of peripheral tolerance or anergy is an important phenomenon which has evolved to 
protect the host against the development of autoimmune responses. Both bacteria and murine viruses 
have developed superantigens as one way to evade the immune system by inducing T cell anergy 
[3,40]. It has become apparent that a state of anergy develops in a portion of the T cells following HIV 
infection, and this anergic state can reduce the antiviral immune response [41,42]. It is important to 
understand  the  mechanisms  responsible  for  the  induction  of  anergy  by  these  micro-organisms. 
Furthermore,  understanding  the  biochemical  basis  of  anergy  induction  may  also  lead  to  the 
development of strategies for the treatment of autoimmune diseases, such as, multiple sclerosis and 
type-1 diabetes [43,44].  
3. Experimental Section 
3.1. Reagents 
C3H/HeN (H-2
k, I-J
k) and B10.A (H-2
k) mice were obtained from the National Cancer Institute 
(Frederick, Maryland).  Staphylococcal  enterotoxin A (SEA) was obtained from Toxin Technology 
(Sarasota,  FL).  The  synthetic  peptide  93–103  corresponding  to  amino  acids  93  to  103 
(DLIAYLKQATK) of pigeon cytochrome C (PCC) and the recombinant human interleukin-2 (IL-2) 
were generous gifts of Dr. Dennis Taub (NCI, Fredrick, MD). The rabbit polyclonal antiserum specific 
for  the  tyrosine  kinase  p56lck  and  the  ζ  chain  were  generous  gifts  of  Dr.  Alexander  Tysgankov 
(Temple University, Philadelphia, PA). The mouse monoclonal antibody specific for tyrosine kinase 
p59  fyn  was  obtained  from  Santa  Cruz  Biotechnology,  Inc.  The  mouse  monoclonal  antibodies  
specific  for  tyrosine  kinase  ZAP-70  and  phosphorylated  tyrosine  residues  were  purchased  from 
Transduction  Laboratories  (Lexington,  KY).  The  mouse  monoclonal  antibody  specific  for  
glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH)  was  purchased  from  Biodesign  International 
(Kennebunk, ME). The murine T helper type-1 T cell clone, A.E7, was derived from B10.A mice by 
Dr. Ronald Schwartz at National Institute of Health (Bethesda, Maryland; [45]). This clone recognizes 
an epitope of PCC composed of amino acids 84 to 104 presented in the context of I-E
k. In addition, this 
clone expresses the T cell receptor (TCR) Vα 11 allele and Vβ 3 allele. The A.E7 T cell clone was 
maintained  in  a  tissue  culture  medium  containing  RPMI-1640  medium,  10%  fetal  calf  serum,  
2 mM glutamine, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 50 µM β-mercaptoethanol, 
and 0.01 mg/mL gentamicin. The A.E7 clone was stimulated every seven days with 0.5 µM synthetic 
peptide 93–103 or 25 µg/mL of PCC presented by irradiated (1500 rads) B10.A splenocytes. Two days 
after stimulation of the clone, recombinant human interleukin 2 (IL-2) was added to the culture at a Toxins 2010, 2  
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final concentration of 20 units/mL. Hybridoma 145-2C11 was obtained from ATCC and produces 
monoclonal hamster antibody specific for the ε chain of murine CD3.  
3.2. T cell activation 
The  A.E7  T  cell  clone  was  cultured  (10
5  cells/well)  in  a  96  well  plate  with  irradiated  
(1500–2000 rads) B10.A splenocytes (2.5 × 10
5 cells/well) and either peptide 93–103 or superantigen 
(SEA or SEB) at various concentrations. The cultures were incubated for two days at 37 °C in a 
humidified incubator with 5% CO2 and 1 µCi of [
3H]-thymidine was then added in each well. The cells 
were harvested using an Inotech 96 well plate harvester onto glass fiber filter paper. The filters were 
subjected to liquid scintillation spectrometry. 
3.3. Anergy induction 
The technique for the analysis of anergic T cells was a modification of the method of Jenkins and 
Schwartz  [12].  In  the  first  stage  of  anergy  induction,  the  A.E7  T  cell  clone  (10
5  cells/well)  was 
cultured in 96 well plates with SEA for two days and the plates were washed a total of three times. The 
plates were recultured in the presence of medium for two additional days. The A.E7 T cell clone was 
then assayed for proliferative capacity in the second stage of the experiment. The cells were again 
washed  in  the  manner  described  above  and  incubated  with  either  medium  alone,  irradiated  APC, 
irradiated APC plus antigen (10 µM), or IL-2 (20 U/mL) for two additional days at 37 °C. Proliferation 
was measured as described above.  
3.4. TCR signaling analysis 
After stimulation with SEA for two days in culture, the A.E7 cells were centrifuged at 250 g for  
10 minutes at 4 °C. The pellets were resuspended in PBS and washed once. The pellets were lysed 
using TNE lysis buffer containing 10 mM Tris-HCl pH 7.6, 50 mM sodium chloride, 0.5% NP-40, and 
5 mM EDTA, 10 µg/mL aprotinin, 1 mM sodium orthovanadate, 1 mM PMSF, and 5 mM sodium 
fluoride for 10 minutes on ice in a 1.5 mL polypropylene eppendorf tube. The lysates were centrifuged 
at  11,000  g  for  4  minutes  at  4  °C.  The  supernatants  were  collected  and  assayed  for  total  protein 
concentration using the BCA Protein Assay kit. Between 100 µg and 2 mg of total protein for each 
immunoprecipitation was set aside. Either polyclonal antiserum for p56 lck or for ζ chain or purified 
antibody specific for p59 fyn and CD3ε was added to the whole lysate in a final volume of 500 µL of 
TNE lysis buffer and incubated at 4 °C for 1 hour. Fifty µL of a 10% pansorbin suspension was added 
to  the  mixture  and  incubated  for  1  hour  at  4  °C  on  an  orbital  rotator.  The  samples  were  then 
centrifuged for 1 minute at 11,000g at 4 °C and the supernatant decanted. The pellet was washed 3 
additional times under these conditions with TNE buffer in the absence of protease inhibitors. The 
pellets  were  incubated  15  to  30  minutes  with  40-50  µL  of  sample  buffer  containing  
20 mM Tris-HCl pH 6.8, 4% sodium dodecyl sulfate, 20% glycerol, 10% β mercaptoethanol, and 
0.006%  bromophenol  blue.  The  samples  were  centrifuged  at  11,000  g  for  1  minute,  and  the 
supernatants  were  removed,  boiled  3-5  minutes,  and  loaded  on  a  10%  SDS-polyacrylamide  gel  Toxins 2010, 2  
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(SDS-PAGE).  Western  blot  analysis  was  performed  and  the  nitrocellulose  paper  was  blotted  with 
either antibodies specific for p56 lck, p59 fyn, ZAP-70, phosphotyrosine residues, or ζ chain. 
The technique for the analysis of early TCR-proximal signaling events was a modification of the 
method of [46]. Briefly, splenocytes from B10.A mice were depleted of T cells as described above. 
These  depleted  splenocytes  were  cultured  in  A.E7  TCM  in  24  well  plates  at  a  density  of  
1–1.5  ×  10
7  cells/well  in  the  presence  or  absence  of  SEA  at  100  ng/mL  final  concentration  for  
30 minutes at 37 °C. The A.E7 clone was then added at a density of 1–1.5 × 10
7 cells/well in a final 
volume of 1.5 mL. The plates were centrifuged at 250 g for 3 minutes in order for the A.E7 cells to 
make contact with the APC monolayer, and were then incubated for either 10, 20, or 30 minutes at  
37  °C.  The  cultures  were  harvested,  the  cells  were  centrifuged  at  250  g  for  10  minutes,  and  the 
supernatants were decanted and the pellets lysed for 10 minutes on ice with 200 to 300 µL of TNE 
lysis buffer containing the protease inhibitors described above. Twenty to 30% of lysate was reserved 
for  immunoblotting  analysis.  The  remaining  lysate  was  used  for  immunoprecipitation  purposes  as 
described above. The content of the immunoprecipitates was analyzed by western blot analysis. 
4. Conclusions 
Superantigens exhibit both stimulatory and suppressive immunomodulatory properties. Here we 
report the proximal signaling events of the TCR in a murine T cell clone during the induction of 
anergy by SEA in the absence of MHC class II bearing cells. Under these conditions, SEA was able to 
induce  unique  signaling  events  when  compared  to  experimental  systems  employing  APCs.  SEA 
stimulation alone failed to induce hyper-phosphorylation of the zeta chain despite inducing a strong 
proliferative  response.  These  data  suggest  that  superantigen  induction  of  anergy  involves  an 
uncoupling of the TCR zeta chain function. Furthermore, these data suggest that superantigen ligation 
with  the  TCR  offers  a  simplified  model  system  of  anergy  induction  where  complicating  signals 
provided by the APC are absent. 
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